GEN

Affymetrix: More Than Microarrays

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
FierceBiotech

Affymetrix and BGI Enter Strategic Collaboration to Co-Develop and Commercialize Genomic Microarrays for the Agricultural

Collaboration to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX), ...
Business Wire

Affymetrix and Ariosa Diagnostics Announce Signing of Multi-Year Supply Agreement in Support of Ariosa’s Non-Invasive Prenatal Test

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
technologynetworks

Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...
The Scientist

Affymetrix Showcases Third-Party Microarray Analysis Software

Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets. Few laboratories have the resources to develop their own ...
FiercePharma

Affymetrix Launches Advanced RNA Amplification Technology for Whole-Genome Expression Analysis of FFPE Samples

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
Nature

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends on ...
GEN

Ingenuity, Affymetrix Pair Products to Curb Microarray Bottlenecks

Ingenuity Systems and Affymetrix will be co-promoting Ingenuity® iReport™ with Affymetrix’ expression microarray products to help eliminate a bottleneck for researchers working with human, mouse, and ...
Business Wire

Affymetrix Commercializes Next-Generation Transcriptome Array for Large-Scale Clinical Studies | Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced commercialization of the next-generation human transcriptome array demonstrated by Stanford University researchers ...
Yahoo Finance

Bionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer

SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Richard Shippy has joined the company as its Chief Business Officer. Richard was one of the ...
FierceBiotech

Affymetrix Launches Advanced RNA Amplification Technology for Whole-Genome Expression Analysis of FFPE Samples

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...